Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial

BACKGROUND: Combination of metformin to reduce the fasting plasma glucose level and an α-glucosidase inhibitor to decrease the postprandial glucose level is expected to generate a complementary effect. We compared the efficacy and safety of a fixed-dose combination of voglibose plus metformin (vogme...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Tae Jung, Yu, Jae Myung, Min, Kyung Wan, Son, Hyun Shik, Lee, Moon Kyu, Yoon, Kun Ho, Song, Young Duk, Park, Joong Yeol, Jeong, In Kyung, Cha, Bong Soo, Kim, Yong Seong, Baik, Sei Hyun, Kim, In Joo, Kim, Doo Man, Kim, Sung Rae, Lee, Kwan Woo, Park, Jeong Hyung, Lee, In Kyu, Park, Tae Sun, Choi, Sung Hee, Park, Sung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581551/
https://www.ncbi.nlm.nih.gov/pubmed/30604594
http://dx.doi.org/10.4093/dmj.2018.0051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581551/
https://www.ncbi.nlm.nih.gov/pubmed/30604594
http://dx.doi.org/10.4093/dmj.2018.0051

Ejemplares similares